PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Phenotype | C0032460|polycystic ovary |
| Sentences | 8 |
| PubMedID- 26104466 | Conclusion: the lipid accumulation product seems to be sufficient to indicate a risk of cardiovascular diseases in women with polycystic ovary syndrome. |
| PubMedID- 22703625 | The aim of this study was to assess relationship of insulin resistance, oxidant-antioxidant status, endothelial dysfunction, lipid metabolism, and their contribution to the risks of cardiovascular disease in women with polycystic ovary syndrome (pcos). |
| PubMedID- 25878664 | Predictors of subclinical cardiovascular disease in women with polycystic ovary syndrome: interrelationship of dyslipidemia and arterial blood pressure. |
| PubMedID- 23362921 | Cardiovascular disease in polycystic ovary syndrome. |
| PubMedID- 21717407 | Background: the increased incidence of cardiovascular disease in women with polycystic ovary syndrome (pcos) has prompted researchers to look for indicators of early atherosclerotic changes in these patients. |
| PubMedID- 26288196 | The incidence of cardiovascular disease (cvd) in patients with polycystic ovary syndrome (pcos) is very high and conventional risk factors only partially explain excessive risk of developing cvd in patients of pcos. |
| PubMedID- 20536945 | However, no studies have determined whether t2dm incidence is reduced, (v) polycystic ovary syndrome is associated with cardiovascular disease (cvd) risk factors but data on cvd incidence are weak, (vi) risk factors for cvd are improved by the same interventions and statins and (vi) no studies have evaluated whether cvd incidence is reduced. |
| PubMedID- 20375205 | Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the androgen excess and polycystic ovary syndrome (ae-pcos) society. |
Page: 1